Alife Health Patents

Patent portfolio assigned to Alife Health (verified via public assignee records). Alife Health (US), AI for IVF/embryology (FDA-cleared Embryo Predict). Customers named in own press / partner newsroom. Patent EP4302264A1 ('evaluating embryo viability using AI') lists Alife Health Inc as assignee.